Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Proteon Thera Com ST (PRTO)

Proteon Thera Com ST (PRTO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,131
  • Shares Outstanding, K 22,179
  • Annual Sales, $ 0 K
  • Annual Income, $ -20,730 K
  • 60-Month Beta 0.50
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.96
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/06/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +370,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.27 +19.07%
on 12/05/19
0.34 -5.64%
on 12/11/19
+0.05 (+16.95%)
since 11/12/19
3-Month
0.22 +46.14%
on 10/31/19
0.46 -29.93%
on 09/24/19
-0.05 (-14.04%)
since 09/12/19
52-Week
0.22 +46.14%
on 10/31/19
3.94 -91.84%
on 03/13/19
-1.52 (-82.53%)
since 12/12/18

Most Recent Stories

More News
Rigrodsky & Long, P.A. Files Class Action Suit Against Proteon Therapeutics, Inc.

Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Proteon Therapeutics, Inc. ("Proteon")...

PRTO : 0.32 (unch)
Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina Trust BancShares (CART), and Highlands Bankshares (HLND) Investors to Contact Firm

Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary...

LPT : 59.94 (-0.97%)
PRTO : 0.32 (unch)
RARX : 47.35 (+0.04%)
CART : 12.72 (+2.37%)
HLND : 8.1700 (+1.36%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

Rigrodsky & Long, P.A. announces that it is investigating:

CARO : 43.09 (+2.45%)
PRTO : 0.32 (unch)
TECD : 143.23 (-0.06%)
CISN : 9.98 (+0.10%)
Moore Kuehn, PLLC Encourages Vitamin Shoppe, Inc. (VSI), Jagged Peak Energy Inc. (JAG), Proteon Therapeutics, Inc. (PRTO), and Roan Resources, Inc. (ROAN) Investors to Contact Firm

Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary...

VSI : 6.50 (unch)
JAG : 7.72 (+5.61%)
PRTO : 0.32 (unch)
ROAN : 1.52 (unch)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Proteon Therapeutics, Inc. ("PRTO" or the "Company") (NASDAQ: PRTO) in connection...

PRTO : 0.32 (unch)
Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - FCSC, PRTO, ARTX, ROAN

Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

FCSC : 3.00 (unch)
PRTO : 0.32 (unch)
ARTX : 2.99 (-0.33%)
ROAN : 1.52 (unch)
Proteon Therapeutics: 3Q Earnings Snapshot

WALTHAM, Mass. (AP) _ Proteon Therapeutics Inc. (PRTO) on Thursday reported a loss of $1.5 million in its third quarter.

PRTO : 0.32 (unch)
Proteon Therapeutics Announces Third Quarter 2019 Financial Results

Proteon Therapeutics, Inc. ("Proteon" or the "Company") (Nasdaq: PRTO), a company that has historically focused on the development of novel, first-in-class pharmaceuticals to address the medical needs...

PRTO : 0.32 (unch)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Acquisitions

Rigrodsky & Long, P.A. announces that it is investigating:

ACHN : 6.21 (+0.32%)
PRTO : 0.32 (unch)
JAG : 7.72 (+5.61%)
JDRF T1D Fund Appoints Veteran Life Sciences Executive Dr. Steven St. Peter as Managing Director

The JDRF T1D Fund, the venture philanthropy fund focused on accelerating life-changing solutions to cure, prevent, and treat type 1 diabetes (T1D) through catalytic investments, today announced the expansion...

PETX : 4.92 (-0.20%)
RYTM : 24.91 (+0.61%)
SNDX : 8.86 (+1.03%)
PRTO : 0.32 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade PRTO with:

Business Summary

Proteon Therapeutics Inc. is a biopharmaceutical company. The Company is developing pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. It is developing PRT-201, a recombinant human elastase, applied in a single treatment to the external surface of arteries and...

See More

Key Turning Points

2nd Resistance Point 0.35
1st Resistance Point 0.33
Last Price 0.32
1st Support Level 0.31
2nd Support Level 0.30

See More

52-Week High 3.94
Fibonacci 61.8% 2.52
Fibonacci 50% 2.08
Fibonacci 38.2% 1.64
Last Price 0.32
52-Week Low 0.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar